Securing the Supply Chain
John Bass is the Founder & CEO of Hashed Health, an award-winning venture studio building startups that improve the health of individuals and communities through innovation and radical collaboration.Hashed Health partners with enterprises to build and launch innovative businesses in areas such as credentialing, supply chain, workforce solutions, and marketplaces.John is an internationally recognized author and speaker on healthcare innovation and web3 technologies. Before starting Hashed, John was CEO at InVivoLink (sold to HCA). John’s experience includes startup empactHealth.com (sold to GHX).  
John Bass is the Founder & CEO of Hashed Health, an award-winning venture studio building startups that improve the health of individuals and communities through innovation and radical collaboration.Hashed Health partners with enterprises to build and launch innovative businesses in areas such as credentialing, supply chain, workforce solutions, and marketplaces.John is an internationally recognized author and speaker on healthcare innovation and web3 technologies. Before starting Hashed, John was CEO at InVivoLink (sold to HCA). John’s experience includes startup empactHealth.com (sold to GHX).  
Keren Haruvi is President of Sandoz US and Head of North America. In this role, she leads Sandoz’ largest commercial and country organization – the United States – which is responsible for over 35% of Sandoz global revenue. She also oversees Sandoz commercial operations in Canada. In addition to serving on the Novartis Country Leadership Team, Keren is a member of the Global Sandoz Executive Committee.
Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management. Over the years, she demonstrated her prowess in knowing when to walk away and when to drive deals from identification through execution to closing, integration, and rationalization.
Keren is a value creator in the biopharmaceutical space. She brings 17 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations, and complex market strategies for large-scale, sustainable growth. She is known as an authentic, empathetic, and inspirational champion of teams with an unparalleled appreciation and vision for what can be accomplished when diverse stakeholders are mobilized around common goals and objectives.
Keren holds an MBA in Finance from Bar Ilan University and a Bachelor’s degrees in Economics and Chemistry from Tel Aviv University. Nominated for Top 40 Under 40 in The Marker magazine, she exemplifies the insight and wisdom needed to move global organizations forward. Outside of work, Keren enjoys spending time with her 5 children. She is an avid runner with one marathon and 3 half-marathons under her belt.
Keren Haruvi is President of Sandoz US and Head of North America. In this role, she leads Sandoz’ largest commercial and country organization – the United States – which is responsible for over 35% of Sandoz global revenue. She also oversees Sandoz commercial operations in Canada. In addition to serving on the Novartis Country Leadership Team, Keren is a member of the Global Sandoz Executive Committee.
Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management. Over the years, she demonstrated her prowess in knowing when to walk away and when to drive deals from identification through execution to closing, integration, and rationalization.
Keren is a value creator in the biopharmaceutical space. She brings 17 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations, and complex market strategies for large-scale, sustainable growth. She is known as an authentic, empathetic, and inspirational champion of teams with an unparalleled appreciation and vision for what can be accomplished when diverse stakeholders are mobilized around common goals and objectives.
Keren holds an MBA in Finance from Bar Ilan University and a Bachelor’s degrees in Economics and Chemistry from Tel Aviv University. Nominated for Top 40 Under 40 in The Marker magazine, she exemplifies the insight and wisdom needed to move global organizations forward. Outside of work, Keren enjoys spending time with her 5 children. She is an avid runner with one marathon and 3 half-marathons under her belt.
Christopher Fortier is currently the Chief Pharmacy Officer at Massachusetts General Hospital (MGH) in Boston.  Additionally, Chris chairs the Mass General Brigham Chief Pharmacy Officer’s Council.
Chris received his Doctor of Pharmacy degree from the University of Connecticut School of Pharmacy and completed a PGY-1/PGY-2 Health-System Pharmacy Administration Residency at the Medical University of South Carolina Medical Center in Charleston, SC.  He has given over 100 national and international presentations and has academic appointments at University of North Carolina – Chapel Hill, University of Connecticut, and Northeastern University.
Chris has served in healthcare leadership roles for numerous state and national professional organizations, has published in multiple healthcare journals, and has been featured in a variety of media outlets including NBC Nightly News, the Associated Press, the Wall Street Journal, and National Public Radio.
Christopher Fortier is currently the Chief Pharmacy Officer at Massachusetts General Hospital (MGH) in Boston.  Additionally, Chris chairs the Mass General Brigham Chief Pharmacy Officer’s Council.
Chris received his Doctor of Pharmacy degree from the University of Connecticut School of Pharmacy and completed a PGY-1/PGY-2 Health-System Pharmacy Administration Residency at the Medical University of South Carolina Medical Center in Charleston, SC.  He has given over 100 national and international presentations and has academic appointments at University of North Carolina – Chapel Hill, University of Connecticut, and Northeastern University.
Chris has served in healthcare leadership roles for numerous state and national professional organizations, has published in multiple healthcare journals, and has been featured in a variety of media outlets including NBC Nightly News, the Associated Press, the Wall Street Journal, and National Public Radio.
Daniel J. Hoey is an industry leader in pharmaceutical product development, manufacturing operations and supply chain management with over 30 years of experience in the industry. Prior to joining EQRx, Dan led global supply chain management at Teva, where he drove the transformation of one of the largest and most complex global pharmaceutical supply chains focused on patient-centric healthcare solutions.Previously, Dan led manufacturing and supply chain operations in global leadership roles at Teva API and Biologics, as well as Merck, where he spent 27 years in manufacturing operations, commercialization, strategy development and contract manufacturing. Dan is certified in application of lean manufacturing and six-sigma process improvement inpharmaceutical operations.Dan holds a Bachelor of Science in Chemical Engineering from Michigan State University.
Daniel J. Hoey is an industry leader in pharmaceutical product development, manufacturing operations and supply chain management with over 30 years of experience in the industry. Prior to joining EQRx, Dan led global supply chain management at Teva, where he drove the transformation of one of the largest and most complex global pharmaceutical supply chains focused on patient-centric healthcare solutions.Previously, Dan led manufacturing and supply chain operations in global leadership roles at Teva API and Biologics, as well as Merck, where he spent 27 years in manufacturing operations, commercialization, strategy development and contract manufacturing. Dan is certified in application of lean manufacturing and six-sigma process improvement inpharmaceutical operations.Dan holds a Bachelor of Science in Chemical Engineering from Michigan State University.